Mon, Oct 20, 2014, 9:36 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Northwest Biotherapeutics, Inc. Message Board

  • incar92 incar92 Mar 12, 2014 12:42 PM Flag

    TELL ME, LONGS---when is overdue, "overdue"...

    is there some point in time when longs acknowledge that interim results are overdue--or do they just hide their heads in the sand forever?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The DMC started supplying due dates to thier recommendations? Incar, when did this start?

    • incar92. It really doesn't matter if the answer is positive. Or as they might say in the past " If it was up your Booty you would know". In for the duration +six

    • no one has any control over when the DSC completes the efficacy part of the review, safety is good and we will see what we get when DSC is finished. the only point you might think about is : GERMANY
      This looks like a tell to some or a red flag to AF's followers that are long GERN & VVUS
      "The Paul Ehrlich Institute (( PEI )) which is the German equivalent of the FDA has just approved a hospital exemption early access program (similar to compassionate use) for DCVax-L to treat all glioma patients. This Hospital Exemption approval was issued under section 4 ( B ) of the German Medicines Law in which PEI has the authority to provide an exemption from the requirement that a product must complete clinical trials establishing safety and efficacy and then gain regulatory approval before the product can be made available to patients."

    • This is my last answer to your question: if you can read and do just a little DD and then you would understand: this is not "overdue" (a word used first by #$%$ AF). As a matter of fact, it is simply still under review by DMC, which no ones not linda, not you and me can control! When DMC does its review and notifies the company, then the company can make a public announcement. Is that clear?

4.84+0.26(+5.68%)Oct 20 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.